Clinical Trial: Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.

U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396337) titled 'Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.' on Feb. 01.

Brief Summary: The purpose of this study is to determine the efficacy and safety of QHRD106 injection in treating acute ischemic stroke.

Study Start Date: Jan. 19

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: QHRD106 Injection (Low-dose group)

Participants will receive QHRD106 injection (5600 IU) every 7 days with a total of 3 doses.

DRUG: QHRD106 Injection (Middle-dose group)

Participants will receive QHRD106 injection (8400 IU) every 7 days with a total of 3 doses.

DRUG: QHRD106 Injection ...